Terms: = Gastric cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Treatment
19 results:
1. [Relationship between PD-L1 expression and tumor stem cell marker CD44 as a promising basis for the development of new approaches to cancer targeted therapy].
Sotnikova TN; Polushkina TV; Danilova NV
Arkh Patol; 2023; 85(6):70-75. PubMed ID: 38010641
[TBL] [Abstract] [Full Text] [Related]
2. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
Lu H; Cao LL; Ballout F; Belkhiri A; Peng D; Chen L; Chen Z; Soutto M; Wang TC; Que J; Giordano S; Washington MK; Chen S; McDonald OG; Zaika A; El-Rifai W
Gut; 2023 Dec; 73(1):47-62. PubMed ID: 37734913
[TBL] [Abstract] [Full Text] [Related]
3. A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma.
Chen B; Yao Y; Mao D; Li C; Wang X; Sheng S; Zhang L; Wang X; Chen S; Xu W; Deng J; Sun C; Zhou Q; Lowe S; Bentley R; Shao W; Li H
Front Immunol; 2022; 13():928742. PubMed ID: 35935979
[TBL] [Abstract] [Full Text] [Related]
4. Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer.
Zhang C; Chong X; Jiang F; Gao J; Chen Y; Jia K; Fan M; Liu X; An J; Li J; Zhang X; Shen L
J Extracell Vesicles; 2022 Apr; 11(4):e12209. PubMed ID: 35362262
[TBL] [Abstract] [Full Text] [Related]
5. PD-L1 Status in gastric cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation.
Spirina L; Avgustinovich A; Afanas'ev S; Volkov M; Dobrodeev A; Cheremisina O; Kostromitsky D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681840
[TBL] [Abstract] [Full Text] [Related]
6. The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in gastric cancer treatment.
Bolandi N; Derakhshani A; Hemmat N; Baghbanzadeh A; Asadzadeh Z; Afrashteh Nour M; Brunetti O; Bernardini R; Silvestris N; Baradaran B
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639059
[TBL] [Abstract] [Full Text] [Related]
7. Advanced breast cancer with cachexia: A case report.
Liu N; Li S; Jia J; Qiao Y; Li Y
Medicine (Baltimore); 2021 Jan; 100(4):e24397. PubMed ID: 33530236
[TBL] [Abstract] [Full Text] [Related]
8. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
[TBL] [Abstract] [Full Text] [Related]
9. From Tumor Immunology to Immunotherapy in gastric and Esophageal cancer.
Vrána D; Matzenauer M; Neoral Č; Aujeský R; Vrba R; Melichar B; Rušarová N; Bartoušková M; Jankowski J
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577521
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial.
Touchefeu Y; Guimbaud R; Louvet C; Dahan L; Samalin E; Barbier E; Le Malicot K; Cohen R; Gornet JM; Aparicio T; Nguyen S; Azzedine A; Etienne PL; Phelip JM; Hammel P; Chapelle N; Sefrioui D; Mineur L; Lepage C; Bouche O
Gastric Cancer; 2019 May; 22(3):577-586. PubMed ID: 30311042
[TBL] [Abstract] [Full Text] [Related]
11. Current and future biomarkers in gastric cancer.
Abbas M; Faggian A; Sintali DN; Khan GJ; Naeem S; Shi M; Dingding C
Biomed Pharmacother; 2018 Jul; 103():1688-1700. PubMed ID: 29864959
[TBL] [Abstract] [Full Text] [Related]
12. Immune Activation and Benefit From Avelumab in EBV-Positive gastric cancer.
Panda A; Mehnert JM; Hirshfield KM; Riedlinger G; Damare S; Saunders T; Kane M; Sokol L; Stein MN; Poplin E; Rodriguez-Rodriguez L; Silk AW; Aisner J; Chan N; Malhotra J; Frankel M; Kaufman HL; Ali S; Ross JS; White EP; Bhanot G; Ganesan S
J Natl Cancer Inst; 2018 Mar; 110(3):316-320. PubMed ID: 29155997
[TBL] [Abstract] [Full Text] [Related]
13. Viral-induced Modulation of Multiple Checkpoint Proteins in cancers.
Nuovo GJ; Folcik VA; Magro C
Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):407-414. PubMed ID: 28697066
[TBL] [Abstract] [Full Text] [Related]
14. Immunotherapy for gastric cancers: emerging role and future perspectives.
Bonotto M; Garattini SK; Basile D; Ongaro E; Fanotto V; Cattaneo M; Cortiula F; Iacono D; Cardellino GG; Pella N; Fasola G; Antonuzzo L; Silvestris N; Aprile G
Expert Rev Clin Pharmacol; 2017 Jun; 10(6):609-619. PubMed ID: 28349740
[TBL] [Abstract] [Full Text] [Related]
15. Elemene Induces Apoptosis of Human gastric cancer Cell Line BGC-823 via Extracellular Signal-Regulated Kinase (ERK) 1/2 Signaling Pathway.
Li P; Zhou X; Sun W; Sheng W; Tu Y; Yu Y; Dong J; Ye B; Zheng Z; Lu M
Med Sci Monit; 2017 Feb; 23():809-817. PubMed ID: 28196062
[TBL] [Abstract] [Full Text] [Related]
16. [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].
Dreyer C; Afchain P; Trouilloud I; André T
Bull Cancer; 2016; 103(7-8):643-50. PubMed ID: 27345450
[TBL] [Abstract] [Full Text] [Related]
17. Astragalus mongholicus regulate the Toll-like-receptor 4 meditated signal transduction of dendritic cells to restrain stomach cancer cells.
Tian Y; Li X; Li H; Lu Q; Sun G; Chen H
Afr J Tradit Complement Altern Med; 2014; 11(3):92-6. PubMed ID: 25371568
[TBL] [Abstract] [Full Text] [Related]
18. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression.
Duman S; Töz H; Aşçi G; Alper S; Ozkahya M; Unal I; Celik A; Ok E; Başçi A
Nephrol Dial Transplant; 2002 May; 17(5):892-6. PubMed ID: 11981080
[TBL] [Abstract] [Full Text] [Related]
19. Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
Wollner N; Lieberman P; Exelby P; D'angio G; Burchenal J; Fang S; Murphy ML
Br J Cancer Suppl; 1975 Mar; 2():337-42. PubMed ID: 1058708
[TBL] [Abstract] [Full Text] [Related]
